TransMedics is a privately held medical technology company dedicated to extending the life-saving benefits of organ transplantation to patients suffering from end-stage organ failure. Headquartered in Andover, Massachusetts, the company was founded in 1998 to address the unmet need for better organ transplant technologies. The Organ Care System™ (OCS™) is designed to help increase the number of organs utilized for transplantation, improve the health of organs being transplanted, improving outcomes and reducing recovery time, and lessen reliance on ongoing medical therapies. The system has CE Marking in Europe and is in routine commercial use for both the OCS Heart and OCS Lung systems. Pivotal IDE clinical trials are being concluded and marketing applications are being prepared for the FDA applications in the United States.
Ed Kania is on the Board of Directors.